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Transient receptor potential channel 1 (TRPC1) is a nonselective cation channel that is required for Ca2 homeostasis necessary
for cellular functions. However, whether TRPC1 is involved in infectious disease remains unknown. Here, we report a novel
function for TRPC1 in host defense against Gram-negative bacteria. TRPC1/mice exhibited decreased survival, severe lung
injury, and systemic bacterial dissemination upon infection. Furthermore, silencing of TRPC1 showed decreased Ca2 entry,
reduced proinflammatory cytokines, and lowered bacterial clearance. Importantly, TRPC1 functioned as an endogenous Ca2
entry channel critical for proinflammatory cytokine production in both alveolar macrophages and epithelial cells. We further
identified that bacterium-mediated activation of TRPC1 was dependent on Toll-like receptor 4 (TLR4), which induced endoplas-
mic reticulum (ER) store depletion. After activation of phospholipase C (PLC-), TRPC1mediated Ca2 entry and triggered
protein kinase C (PKC) activity to facilitate nuclear translocation of NF-B/Jun N-terminal protein kinase (JNK) and aug-
ment the proinflammatory response, leading to tissue damage and eventually mortality. These findings reveal that TRPC1 is re-
quired for host defense against bacterial infections through the TLR4-TRPC1-PKC signaling circuit.
Pseudomonas aeruginosa and Klebsiella pneumoniae are oppor-tunistic Gram-negative bacteria that infect a broad range of
individuals, particularly immunocompromised people, causing
high morbidity and mortality. These bacteria are increasingly be-
coming resistant to almost all the conventional antibiotics and
remain major health threats (1, 2). Better understanding of the
mechanism of host-pathogen interaction may facilitate the devel-
opment of novel approaches to treat these infections. A number of
studies have thus far focused on the pathogenesis of P. aeruginosa
and K. pneumoniae in airway infectious diseases and have identi-
fied some critical innate immunity regulators for early-stage host
defense (3–5).
Members of the transient receptor potential channel (TRPC)
and Orai families have been suggested as mediators of Ca2 entry
channels in nonexcitable cells (6). Activation of the phospholipase
C (PLC) signaling pathway generates inositol trisphosphate (IP3)
and diacylglycerol (DAG), which initiates Ca2 release from the
endoplasmic reticulum (ER) stores followed by the activation of
Ca2 entry channels that increase cytosolic Ca2 levels (7, 8).
Ca2 entry through receptor-mediated channels is essential for
regulating cellular functions, and TRPC1, which functions as a
nonselective cation channel in many cell types, has been shown to
be important in Ca2 entry that is initiated by store depletion (7,
9). In particular, TRPC1 is reportedly associated with cell prolif-
eration, cell migration, enzyme and fluid secretion, normal me-
tabolism in various organ systems, and cancer metastasis (6, 10,
11). TRPC1 could also form a heteromultimer with Orai1 and
stromal interaction molecule 1 (STIM1), which are essential for
Ca2 signaling (12–14). This interaction may allow the activation
of immune ligands (e.g., Toll-like receptors [TLRs]), and thus
TRPC channel proteins may play a role in host defense, which has
been demonstrated only in the context of lipopolysaccharide
(LPS) by regulating cytokine production and inflammatory re-
sponse. Although TRPC1 is reportedly involved in LPS-induced
sepsismodels (15), its role inwhole-microorganism infections has
not been investigated.
Here, we set out to characterize the role of TRPC1 in infection
of whole P. aeruginosa andK. pneumoniae bacteria and the poten-
tialmolecularmechanismusing bothmouse and cell culturemod-
els. We report for the first time that TRPC1 and its associated
endogenous Ca2 channel participate in cytokine production in
both lung alveolar macrophages and epithelial cells. The Ca2
entry via TRPC1 positively modulates inflammatory responses, as
TRPC1 deficiency results in decreased Ca2 entry and increased
infection susceptibility. After PLC- activation, TLR4-mediated
TRPC1 induces protein kinase C (PKC) phosphorylation,
which in turn induces Jun N-terminal protein kinase (JNK)/
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NF-B nuclear translocation, augmenting the production of pro-
inflammatory cytokines.
MATERIALS AND METHODS
Animals. TRPC1 knockout (KO) (TRPC1/) and wild-type (WT) mice
were bred at the animal facility as described in reference 16. Animals were
kept in a specific-pathogen-free facility of theUniversity ofNorthDakota.
All animal studies were performed in accordance with the guidelines ap-
proved by the Institutional Animal Care and Use Committee (IACUC
number 1204-5).
Primary cells and cell lines. Alveolar macrophages (AM) were iso-
lated by bronchoalveolar lavage (BAL) and maintained in RPMI 1640
(Invitrogen, Grand Island, NY) supplemented with 10% fetal bovine se-
rum (FBS). Murine MLE-12 lung type II epithelial cells were obtained
from the American Type Culture Collection (Manassas, VA) and cultured
according to the manufacturer’s instructions.
Preparation of bacteria and infection. The P. aeruginosa WT strain
PAO1 was kindly provided by S. Lory (Harvard University, Boston, MA)
(17). The K. pneumoniae WT strain was kindly provided by V. Miller
(Washington University, St. Louis, MO) (18). PAK and green fluorescent
protein (GFP)-PAO1 were obtained from G. Pier (Channing Laboratory,
HarvardMedical School, Boston,MA) (19). Another P. aeruginosa strain,
Xen-41, expressing luciferase bioluminescence was purchased from Cali-
per Company (Perkin-Elmer, Hopkinton, MA). Bacteria were grown for
about 16 h in LB broth at 37°Cwith shaking. The bacteria were pelleted by
centrifugation at 5,000 g. MLE-12 or MH-S cells were transfected with
TRPC1, TLR2, TLR4, or PKC small interfering RNA (siRNA) (50 nM)
(Santa Cruz Biotechnology, Santa Cruz, CA) using Lipofectamine 2000
reagent (Invitrogen, Grand Island, NY) according to the manufacturer’s
instruction for 24 h. Cells were washed once with serum-free and antibi-
otic-free medium and changed to serum-free and antibiotic-free medium
before infection. Cells were infected by bacteria at a multiplicity of infec-
tion (MOI) of 10:1 (bacterium/cell ratio) for 1 h. Cells were treated with
various inhibitors 30 min before bacterial infection. Mice were anesthe-
tized with 45 mg/kg ketamine and then intranasally instilled with 1 107
CFU of P. aeruginosa and 1 105 CFU for K. pneumoniae in 50 l phos-
phate-buffered saline (PBS), quantified by growing bacteria on conven-
tional agar dishes as described previously (3). Mice were monitored for
symptoms and euthanizedwhen theyweremoribund. Following bacterial
infection, BAL was performed to isolate AM to determine cytokine levels
in BAL fluid using enzyme-linked immunosorbent assay (ELISA).
Electrophysiology. For patch clamp experiments, cells seeded on
coverslips were transferred to the recording chamber and perfused
with an external Ringer solution with the following composition (mill-
imolar): NaCl, 145; CsCl, 5; MgCl2, 1; CaCl2, 1; HEPES, 10; and glu-
cose, 10 (pH 7.4 [NaOH]). All electrophysiological experiments were
performed using a previously described protocol (20, 21). Briefly,
whole-cell currents were recorded using an Axopatch 200B (Axon In-
struments, Inc.). The patch pipette had resistances between 3 and 5
M	 after filling with the standard intracellular solution containing the
following (millimolar): cesium methane sulfonate, 150; NaCl, 8;
HEPES, 10; and EGTA, 10 (pH 7.2 [CsOH]). With a holding potential
of 0 mV, voltage ramps ranging from100 mV to100 mV and with
a duration of 100 ms were delivered at 2-s intervals after a whole-cell
configuration was formed. Currents were recorded at 2 kHz and digi-
tized at 5 to 8 kHz. pClamp 10.1 software was used for data acquisition
and analysis. Basal leakage was subtracted from the final currents, and
average currents were shown. All experiments were carried out at
room temperature.
Calcium measurements. Cells were incubated with 2 M Fura-2
(Molecular Probes) for 45min and washed twice with Ca2-free standard
external solution (SES) (10 mM HEPES, 120 mM NaCl, 5.4 mM KCl, 1
mMMgCl2, 10mMglucose, pH 7.4). For fluorescencemeasurements, the
fluorescence intensity of Fura-2-loaded control cells was monitored with
a charge coupled-device (CCD) camera-based imaging system (Compix)
mounted on an Olympus XL70 inverted microscope equipped with an
Olympus 40 (numerical aperture [NA], 1.3) objective. A dual-wave-
length monochrometer enabled alternative excitation at 340 and 380 nm,
whereas the emission fluorescence wasmonitored at 510 nmwith anOkra
Imaging camera (Hamamatsu, Japan). The images of multiple cells col-
lected at each excitation wavelength were processed using the C imaging
PCI software (Compix Inc., Cranbery, PA) to provide ratios of Fura-2
fluorescence from excitation at 340 nm to that from excitation at 380 nm
(F340/F380). Fluorescence traces shown represent [Ca2]i values that are
averages from at least 30 to 40 cells and are representative of results ob-
tained in at least 3 or 4 individual experiments in the presence of LPS from
Pseudomonas aeruginosa (100 ng/ml; Sigma-Aldrich, St. Louis, MO) or
1-oleoyl-2-acetyl-glycerol (OAG) (100 M; Sigma-Aldrich).
Bonemarrow chimera transfer.TRPC1/ andWTmicewhich have
the same genetic background were administered antibiotics via treated
drinking water (250 units/ml penicillin and 250 g/ml streptomycin)
(Gibco, Grand Island, NY) beginning 1 day before irradiation and given
lethal total body irradiation (800 rads); 24 h later, they were reconstituted
with bonemarrow cells (1 107) that had been harvested from the femurs
of age-matched mice. Experimental transfers were as follows: WT donors
into WT recipients, WT donors into TRPC1/ recipients, TRPC1/
donors intoWT recipients, and TRPC1/ donors into TRPC1/ recip-
ients. Animals were allowed to reconstitute for 
45 days, and P. aerugi-
nosa infection was performed as described above.
Western blot analysis. Rabbit polyclonal anti-TRPC1 (catalog num-
ber ACC-010) and ORAI1 (catalog number ACC-060) antibodies (Abs)
were purchased from Alomone Labs. Mouse monoclonal Abs against
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (catalog number
sc-137179), gamma interferon (IFN-) (catalog number sc-32813), inter-
leukin-6 (IL-6) (catalog number sc-1265-R), phospho-p38 (catalog num-
ber SC-7973), p38 (catalog number SC-535), phospho-extracellular sig-
nal-regulated kinase (p-ERK) (catalog number SC-7383), ERK (catalog
number SC-271269), and NF-B p65 (catalog number SC-8008), rabbit
polyclonal Abs against TLR4 (catalog number SC-30002), TLR2 (catalog
number SC-10739), IL-12 (catalog number SC-7925), and phospho-
NF-B p65 (Ser536) (catalog number SC-330220-R), and goat polyclonal
Abs against IL-1 (catalog number SC-1252), IL-4 (catalog number sc-
1261),-actin (catalog number sc-1616), and tumor necrosis factor alpha
(TNF-) (catalog number sc-1351) were obtained from Santa Cruz Bio-
technology, Inc. (Santa Cruz, CA). Rabbit monoclonal Abs against phos-
pho-PKC (catalog number 9375), PKC (catalog number 2056), IB
kinase (IKK) (catalog number 34673), phospho-JNK (catalog number
9258), STIM1 (catalog number 4916), SECRA (catalog number 12293),
and JNK (catalog number 9251) were purchased from Cell Signaling
Technology (Cambridge,MA).Mousemonoclonal Abs against IP3 recep-
tor (IP3R) (catalog number 610312) was purchased from BD Biosciences
(San Jose, CA).The samples derived from cells and lung homogenates
were lysed in radioimmunoprecipitation assay (RIPA) buffer and their
protein content quantified using the Bradford method. The cell lysates
were separated by SDS-PAGE on a 12% acrylamide gel. After transfer to a
polyvinylidene difluoride (PVDF) membrane, this membrane was
blocked with blocking buffer containing 5% dry milk and incubated with
different primary and appropriate secondary antibodies. Antibody bind-
ing was revealed by using an ECL kit (Santa Cruz, CA) as described pre-
viously (22).
In vivo imaging. P. aeruginosa strain Xen-41, expressing luciferase
bioluminescence, was purchased from Caliper Company (Perkin-Elmer,
Hopkinton, MA). Bacteria were grown for about 16 h in LB broth at 37°C
with shaking. The bacteria were pelleted by centrifugation at 5,000  g.
TRPC1/mice andWTmice were intranasally challenged with 1 107
CFU/mouse of P. aeruginosa (Xen-41), anesthetized by ketamine, and
then imaged under an Ivis XRII system following the user guide plus
protocols provided by the company (Perkin-Elmer). The mice were then
monitored up to 24 h.
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Histological analysis. Lung tissues were fixed in 4% formalin for 24 h
and then processed for hematoxylin and eosin (H&E) staining in AML
Laboratories, Inc. (Baltimore, MD). The leukocytes were counted using
the normal optical microscope. Histological analysis was performed ac-
cording to previously report (23).
AM isolation. TRPC1/ and WT mice (n  5) were sacrificed im-
mediately prior to lavage, and the animal fur was dampened with 70%
ethanol (EtOH). The mouse tissues were dissected from the neck to ex-
pose the trachea. A small incisionwasmade in the trachea to allow passage
of a 23-gauge lavage tube into the trachea, and then a 23-gauge needle was
carefully passed into the tubing. The mouse lungs are lavaged three times
with 1 ml of PBS. The retained BAL fluid was centrifuged at 600 g for 5
min at 4°C. The recovered supernatants were collected and assessed for
cytokine concentration using ELISA, and cell pellets were resuspended in
200 l of PBS–1% FBS. AM cells obtained from BAL fluid were seeded in
96-well plates and grown overnight.
Confocal microscopy. MLE-12 cells were transfected with TRPC1 or
PKC siRNA for 24 h, and 25 M TRPC1 inhibitor SKF-96365, 3 M
PKC inhibitor Go6976. 20 M JNK inhibitor SP600125 or 50 g/ml
NF-B peptide inhibitor SN50 (Calbiochem, Billerica, MA) was added 30
min before bacterial infection to the indicated cells. Cells were incubated
with primary anti-p-NF-B p65 and p-JNK Abs and the secondary anti-
bodies as described in our previously report (3). DAPI (4=,6=-diamidino-
2-phenylindole) (Sigma-Aldrich) was used to stain the nucleus.
Luciferase assay. Transient transfections were performed with 2 
105 MLE-12 cells plated in 6-well plates by using pNFB-luc plasmid
(Promega,MadisonWI) according to themanufacturer’s instructions. At
24 h after transfection, the cells were infected with bacteria for 1 h. Cell
lysates were subjected to luciferase activity analysis by using a dual-lucif-
erase reporter assay system (Promega, Madison, WI).
Phagocytosis assay. Phagocytosis was performed as described previ-
ously (3) but withminormodifications. TRPC1/ andWTmice (n 5)
were sacrificed immediately prior to lavage, and the animal fur was damp-
ened with 70% EtOH. The mouse tissues were dissected from the neck to
expose the trachea. A small incision was made in the trachea to allow
passage of a 23-gauge lavage tube into the trachea, and then a 23-gauge
needle was carefully passed into the tubing. The mouse lungs are lavaged
three times with 1 ml of PBS. The retained BAL fluid was centrifuged at
600 g for 5 min at 4°C. The recovered supernatants were collected and
assessed for cytokine concentration using ELISA, and cell pellets were
resuspended in 200l of PBS–1% FBS. AM cells obtained from BAL fluid
were seeded in 96-well plates and grown overnight. The same amounts of
AM cells were treated with serum-free medium for 1 h, and then GFP-
PAO1was used to infect the cells at anMOI of 10:1. After a 1-h incubation
at 37°C, the wells were washed and treated with 100 g/ml polymyxin B
for 1 h to kill any remaining extracellular bacteria. The phagocytized bac-
teria were counted using a Synergy HT fluorometer (BioTek) with 485
(20)-nm excitation and 528 (20)-nm emission filters. Background
correction was done for autofluorescence.
EMSA.Nuclear extracts from lung tissue samples with different treat-
ments were isolated with a nuclear extraction kit according to the manu-
facturer’s instructions (Pierce, Rockford, IL). Oligonucleotide labeling
and binding reactionswere performedby using the reagent supplied in the
NF-B p65 electrophoretic mobility shift assay (EMSA) gel shift assay
system (Panomics, Inc.). The membrane was exposed using a Bio-Rad
imaging system (Bio-Rad, Hercules, CA). The specific mobility shift
caused by binding to DNA duplexes was confirmed by adding an excess
amount of cold oligonucleotide to the reaction mixture.
Statistical analysis. All statistical analyses were done with SPSS 19.0
software. Data are presented as mean standard deviation (SD) and are
representative of three experiments. Statistical analysis was performed by
Student’s t test for comparing two groups and by one-way analysis of
variance (ANOVA)with Tukey’s post hoc test formultiple-group compar-
isons. Differences in the mean values were considered to be significant at
a P value of0.05.
RESULTS
Increased infection severity and mortality rates in TRPC1/
mice. TRPC1 has recently been reported to be activated by LPS to
increase cytosolic Ca2 ([Ca2]i) levels (24); however, this chan-
nel protein has not been linked to any infectious disease per se. To
characterize the physiological relevance of TRPC1 in host defense
against bacterial infection in vivo, we used TRPC1/ and WT
mice and intranasally instilled a well-characterized strain (PAO1)
at 1 107 CFU into each mouse. As shown in Fig. 1A, TRPC1/
mice exhibited increased lethality, and at 40 h, all TRPC1/mice
died, whereas majority of WT mice survived at that time.
TRPC1/ mice exhibited an increased dissemination of P.
aeruginosa in the area of the thoracic cavity versus WT mice, es-
pecially after 12 h of infection. WT mice showed efficient clear-
ance of the invading bacteria from 12 to 24 h after PAO1 infection
(Fig. 1B; see Fig. S1A in the supplemental material). At 24 h
postinfection, the lungs of TRPC1/mice also showed structural
damage and increased intensity of bioluminescence compared to
those of WT mice (see Fig. S1B in the supplemental material).
TRPC1/mice also showed significantly increasedCFUof PAO1
(approximately 3-fold) in the lung tissue compared to WT mice
(Fig. 1C). These findings indicate that TRPC1may play an impor-
tant role in host defense.
Leukocyte infiltration in the lung tissue was next assessed. No-
tably, TRPC1/ mice showed a decrease in leukocyte count com-
pared toWTmice, while no significant change was observed in con-
trols without PAO1 infection (Fig. 1D and E). Secreted chemokines
in the supernatant were detected by ELISA, and reduced production
of CCL2 andKC-1was observed in TRPC1/mice (Fig. 1F). These
results suggest that low leukocyte infiltrate may be due to the
defect in chemokine production in TRPC1/ mice upon infec-
tion. Moreover, decreased infiltration of polymorphonuclear
neutrophils (PMN) (a critical phagocyte that eradicates bacteria)
in bronchoalveolar lavage (BAL) fluid and serum was observed,
which excluded possible effects of the genetic alteration in
TRPC1/ mice (see Fig. S1C in the supplemental material).
These data indicate that TRPC1/ animals also exhibited se-
verely impaired pulmonary inflammatory responses to P. aerugi-
nosa challenge.
Bone marrow chimera mouse models confirm the critical
role of host defense by TRPC1. To identify the cell types that are
critically involved in host defense against bacterial infection in
vivo, we generated bone marrow chimera mice to investigate
whether the effects observed in TRPC1/ are reversible. Transfer
of bone marrow cells from TRPC1/ to WT mice (after gamma
radiation) showed a decrease in survival upon bacterial infection
(Fig. 1G), and a corresponding increase in bacterial burdens (see
Fig. S2A in the supplemental material) was observed. In contrast,
transfer of bone marrow cells from WT to TRPC1/ mice
showed increased survival and decreased bacterial burdens (Fig.
1G; see Fig. S2A in the supplemental material), suggesting that
expression of TRPC1onhematopoietic cells is important for com-
bating PAO1 infection. We next evaluated the functional activity
of AMcells obtained fromTRPC1/mice orWTmice and found
that TRPC1/AMcells had significantly lowered phagocytosis of
GFP-PAO1 thanWTAMcells, indicating that TRPC1may also be
involved in the phagocytosis process (see Fig. S2B in the supple-
mental material). These data recapitulated our observations from
TRPC1/mice and strongly support our view that TRPC1 plays
TRPC1 Protects against Bacterial Infection
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a defense role against P. aeruginosa infection. Since bone marrow
myeloid cell transfer only partially rescued the resistance to PAO1
infection, it is possible that alveolar type II (ATII) epithelial cells,
which are an integral part of the lung innate immunity and a
source of proinflammatory cytokines (25, 26), also contribute to
host defense, with these two cells together providing almost full
resistance to infection. Indeed, TRPC1 siRNA and Ca2 channel
inhibitor intervention (SKF-96365) in MLE-12 cells (an alveolar
type II epithelial cell line) infected with PAO1 at an MOI of 10:1
showed a significant increase in bacterial loads (Fig. 1H; see Fig.
S3A in the supplemental material).
Bacterial infection facilitates Ca2 influx.We thus attempted
to evaluate the effect of bacterial infection on [Ca2]i. Intracellu-
lar ER stores were depleted by addition of P. aeruginosa LPS, a
TLR4 activator, in the absence of extracellular Ca2. Subse-
quently, addition of external Ca2, which initiates Ca2 entry
across the plasma membrane to exert cellular functions, resulted
in an increase in Ca2 entry in both control and P. aeruginosa-
treated cells. However, Ca2 entry was significantly increased in
bacterium-infectedMLE-12 cells, without altering the ER calcium
levels (Fig. 2A). Furthermore, depletion of the internal ER store
using thapsigargin also showed a similar increase in Ca2 entry in
P. aeruginosa-treated cells, without affecting basal Ca2 (see Fig.
S3C toE in the supplementalmaterial).We also looked at SERCA2
and IP3R protein levels, but SERCA and IP3R protein levels were
not significantly changed. Similar results were also obtained with
cells infected with another human pathogen, the Gram-negative
K. pneumonia, and an increase in receptor-dependent Ca2 entry
was observed upon infection (Fig. 2B). Importantly, the cells
transfected with TRPC1 siRNA showed a significantly decreased
FIG 1 TRPC1/ mice display increased susceptibility to and mortality rates from P. aeruginosa infection. TRPC1/ mice and WT mice were intranasally
infectedwith 1 107CFU/mouse of PAO1. (A) Survivalwas determinedup to 65 hpostinfection and is represented byKaplan-Meier survival curves (P 0.0223,
log rank test; n 6 in each set of animals). (B) In vivo imaging of PAO1-infected mice (n 5). TRPC1/mice andWTmice were intranasally challenged with
1 107 CFU/mouse of Xen-41 (a bioluminescent strain ofP. aeruginosa). Themicewere thenmonitored up to 24 h. Images showing bioluminescence in the lung
at different time points were obtained using the Ivis XRII system. (C to F) Themice from panel A were sacrificed 24 h after P. aeruginosa infection, and the lungs
were removed. (C) The same quantity of lung tissue was homogenized in PBS and evaluated for bacterial invasion. The data are expressed as CFU/g tissue. (D)
Decreased lung inflammation as assessed by morphological analysis. The lungs were embedded in formalin, and sections were analyzed by H&E staining. (E)
Leukocyte infiltration scores in lungs fromWT and TRPC1/mice. (F) BAL fluid was collected, and CCL-2 and KC-1 levels in the supernatant were measured
by a standard ELISA. (G) Validation of the function of AM from bone marrow chimera mice. TRPC1/ and WT mice were irradiated (800 rads) and
administered antibiotics via treated drinking water (using 250 units/ml penicillin and 250g/ml streptomycin). Tenmillion bonemarrow cells fromdonormice
were injected into each recipient mouse intravenously immediately after the isolation. Forty-five days later, these mice were challenged with P. aeruginosa
infection. Survival was determined up to 96 h. (H) MLE-12 cells were transfected with scrambled siRNA or TRPC1 siRNA for 24 h. The cells were then infected
with PAO1 at an MOI of 10:1 for 1 h, and polymyxin B (100 g/ml) was added and left for another 1 h to kill bacteria outside the cells. Cells were treated with
25 M SKF-96365, a Ca2 channel inhibitor, for 30 min before PAO1 infection. MLE-12 cells were lysed to determine CFU. Survival is represented by
Kaplan-Meier survival curves (P 0.0489, log rank test; n 5 or 6 in each set of animals). For other result comparisons, we used one-way ANOVA with a post
hoc or Student’s t test. *, P 0.05.
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LPS-induced Ca2 entry compared to cells transfected with
scrambled siRNA upon infection (see Fig. S4A in the supplemen-
tal material). To identify the Ca2 entry channel, electrophysio-
logical recordingswere performed, and addition of LPS caused the
appearance of an inward current that was nonselective and re-
versed between 0 and5 mV (Fig. 2C to E). The channel proper-
ties were similar to those previously observed with TRPC1 (8, 11,
16), and PAO1 infection significantly facilitated Ca2 currents
without altering the current-voltage (I-V) relationship (Fig. 2D
and E), which was inhibited in TRPC1-silenced cells (see Fig. S4B
toD in the supplemental material). STIM1 has been shown to be a
regulator of TRPC1-mediated Ca2 entry, and upon store deple-
tion, increased STIM1-TRPC1 interaction was observed in P.
aeruginosa-treated cells (Fig. 2F). Importantly, cells transfected
with STIM1 siRNA also showed a significant decrease in LPS-
induced Ca2 entry in P. aeruginosa-treated cells compared to
cells transfected with scrambled siRNA (see Fig. S4E and F in the
supplemental material).
To determine the physiological relevance, we isolated primary
alveolar epithelial type II (ATII) cells, bone marrow-derived cells,
and primary alveolar macrophages (AM) isolated from control
(WT) andTRPC1/mice to investigatewhether TRPC1 contrib-
utes to the Ca2-mediated cell signals in these cells in response to
bacterial infection. Interestingly, the results showed that Ca2 in-
flux was significantly increased in all three types of cells isolated
from WT mice (albeit with ATII cells being the strongest) that
were infected with P. aeruginosa, compared to uninfected controls
(Fig. 2G to J). However, no significant increase in Ca2 influx was
observed in P. aeruginosa-infected cells isolated from TRPC1/
mice (Fig. 2G to I). In addition, Ca2 influx per sewas significantly
decreased in TRPC1/ cells (Fig. 2G to I). Furthermore, the
channel properties (I-V curve) in AMcells (Fig. 2J) were similar to
those shown in Fig. 2D, which were again significantly decreased
in TRPC1/ cells. Importantly, protein levels of IP3R, SERCA2,
STIM1, and Orai1 were not significantly changed in TRPC1/
mice treated with P. aeruginosa (Fig. 2K), indicating that the loss
of P. aeruginosa-induced Ca2 entry was primarily due to the loss
of TRPC1. This phenomenon was further validated in alveolar
macrophages isolated from bone marrow chimera mice (see Fig.
S2C and D in the supplemental material). Pretreatment of PAO1
also facilitated Ca2 influx induced by 1-oleoyl-2-acetyl-glycerol
(OAG); however, prolonged treatment with OAG was needed for
a significant increase in [Ca2]i, and the relative Ca
2 influx was
significantly lower than with LPS (see Fig. S4G in the supplemen-
FIG 2 Bacterial infection induces Ca2 influx via the TRPC1 channel. (A and B) Ca2 imaging was performed in the presence of P. aeruginosa (Pa) LPS (100
ng/ml) in control, P. aeruginosa-treated, orK. pneumoniae-treated (15min)MLE-12 cells. Analog plots of the fluorescence ratio (340/380) from an average of 40
to 60 cells’ peak values are shown andwere quantified. (C) LPS-induced currents were evaluated in control and P. aeruginosa-treated (15min)MLE-12 cells. The
holding potential for current recordings was 80 mV. (D and E) Representative I-V curves under these conditions (D) and the average (8 to 10 recordings)
current intensity (at80 mV) (E) in control and P. aeruginosa-treated cells. (F) Coimmunoprecipitates (IP) of MLE-12 cells using STIM1 antibodies in control
cells and cells treated with P. aeruginosa (30min) plus LPS (5min). (G to I) Ca2 imaging was performed in the presence of LPS (100 ng/ml) on primary alveolar
epithelial type II cells (G), primary bone marrow-derived macrophages (H), and alveolar macrophages (AM) (I) isolated from wild-type (WT) and TRPC1/
mice with and without P. aeruginosa infection. Analog plots of the fluorescence ratio (340/380) from an average of 40 to 60 cells are shown and were quantified
(shown as bar graph). (J) Representative I-V curves forWT and TRPC1 knockdown primary AMupon P. aeruginosa infection. (K) Evaluation of IP3R, SERCA2,
STIM1, andORAI1 protein levels byWestern blotting from lung tissues in control andTRPC1/micewith andwithoutP. aeruginosa treatment.-Actin served
as the loading control. All data (representative of three experiments) are plotted as means SD (*, P 0.05), and the statistical methods used were one-way
ANOVA coupled with a post hoc (three groups or more) or Student t (two groups) test unless stated otherwise.
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tal material). Overall, these results indicate that both P. aeruginosa
and K. pneumoniae infections facilitate [Ca2]i via the TRPC1
channel.
TRPC1 deficiency hampers the JNK/NF-B pathway against
P. aeruginosa infection. To evaluate the downstream signaling
events, we evaluated several kinase proteins and cytokines in cell
culture models. Both TRPC1 siRNA-transfected cells and Ca2
entry inhibitor (SKF-96365)-treated cells demonstrated a de-
crease in the phosphorylation of JNK and NF-B, which may be
associated with the lowered secretion of IL-6 and TNF-, whereas
there was no significant change in the phosphorylation of p38 and
ERK1/2 (Fig. 3A; see Fig. S5A in the supplementalmaterial). These
data indicate that the infection phenotypes may be attributed to a
dysregulated proinflammatory response through the TRPC1/
JNK/NF-B axis. Further, immunofluorescence showed that both
JNK and NF-B were activated and were translocated into the
nucleus in control MLE-12 cells but not in TRPC1 siRNA-trans-
fected or SKF-96365-treated MLE-12 cells (Fig. 3B), suggesting
that TRPC1 may facilitate the nuclear translocation of these tran-
scription factors to initiate inflammatory cytokinemRNA synthe-
sis when the host is challenged with bacteria.
To further validate the inflammatory response inMLE-12 cells,
we assessed the expression and activation levels of these proteins
in vivo. Importantly, the phosphorylation level of JNK was found
to be decreased in the lungs of TRPC1/mice compared to those
of WT mice (Fig. 3C; see Fig. S5B in the supplemental material).
Our data also showed that IKK expression and NF-B phos-
phorylation significantly decreased in the lungs of TRPC1/
mice compared to those of WT mice (Fig. 3C; see Fig. S5B in the
supplemental material). Additionally, JNK and NF-B were acti-
vated in a time-dependent manner upon bacterial infection (see
Fig. S6 in the supplemental material).
To convincingly demonstrate the activation of NF-B, we also
examined the translocation of p-JNK and p-NF-B using phar-
maceutical inhibitors. The nuclear translocation of NF-B (p65
subunit) was abolished by both the JNK inhibitor and the NF-B
inhibitor as demonstrated by immunofluorescence staining.
However, JNKwas still activated and translocated into the nucleus
FIG 3 TRPC1 silencing suppresses the JNK/NF-B pathway by P. aeruginosa infection. (A) MLE-12 cells were transfected with scrambled siRNA or TRPC1
siRNA for 24 h. The cells were then infected with PAO1 at anMOI of 10:1 for 1 h, and polymyxin B (100g/ml) was added and left for another 1 h to kill bacteria
outside the cells. Cells were treated with 25MSKF-96365 for 30min before PAO1 infection. The samples were used to determine activation of the JNK/NF-B
pathways and other related signaling proteins by Western blotting. (B) Confocal fluorescence results showed the translocation of p-JNK and p-NF-B p65
(Ser536) inMLE-12 cells from panel A using immune staining. DAPI was used to stain the nucleus. (C)WT and TRPC1/mice were intranasally infected with
1 107 CFUof PAO1 for 24 h (n 5). p-JNK, JNK, p-p38, p38, p-ERK, ERK, IKK, and p-NF-Bp65 (Ser536) levels were determined byWestern blotting from
lung tissues. GAPDH served as the loading control. (D) The nuclear fraction of lung tissue of mice infected with PAO1 for 24 h was isolated using a nuclear
extraction kit (Pierce; number 78833).NF-B expressionwas detected byWestern blotting, and histone 4was used as a loading control. (E) EMSAwas performed
using a biotin-labeled probe, which contains only a single copy of the 21-bp element. Shown are results from reactions performed in the presence of WTmouse
lung tissue nuclear extract (2g; lane 1), TRPC1KOmouse lung tissue nuclear extract (2g; lane 2), P. aeruginosa-treatedWTmouse lung tissue nuclear extract
(2g; lane 3), and P. aeruginosa-treated TRPC1KOmouse lung tissue nuclear extract (2g; lane 4) (24-h P. aeruginosa infection). (F) Cytokines in the BAL fluid
from panel C were measured using ELISA. (G) Lung tissues from panel C were lysed to assess the levels of various cytokines. One-way ANOVA with a post hoc
or Student t test was used. *, P 0.05. The data are representative of three experiments.
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in the presence of the NF-B inhibitor (see Fig. S7A in the supple-
mental material). Consistent with the immunofluorescence anal-
ysis, a luciferase promoter assay showed the activation ofNF-B in
the control group, but this was significantly impaired in the pres-
ence of either the JNK inhibitor (SP600125) or the Ca2 entry
inhibitor (SKF-96365) (see Fig. S7B in the supplemental mate-
rial). Moreover, nuclear fractions of lung tissue were also isolated
to evaluateNF-B levels byWestern blotting. As shown in Fig. 3D,
NF-B levels increased in the nuclei of WT mice upon P. aerugi-
nosa infection, while they were not significantly changed in P.
aeruginosa-infected TRPC1/ mice versus control mice. To
clearly identify molecular evidence of the nuclear translocation,
we performed an electrophoretic mobility shift assay (EMSA)
and showed obviously retarded mobility in WT mice versus
TRPC1/mice (Fig. 3E). Although lung homogenates contain a
myriad of cells, alveolar epithelial cells are the main cell popula-
tion and thus likely contribute predominantly to the result of
NF-B translocation.
To further investigate whether TRPC1 directly impacts cyto-
kine production in vivo, we measured cytokines in BAL fluid and
noted a significant difference in inflammatory cytokines between
TRPC1/mice and control mice. In the lungs of PAO1-infected
TRPC1/mice, the cytokine levels of IL-1, IL-12 (p35), IL-6,
and TNF-were significantly decreased compared to those inWT
mice (Fig. 3F). These results were further corroboratedwithWest-
ern blotting, with decreased levels of IL-1, IL-12 (p35), IL-6,
and TNF- in TRPC1/ lung tissues infected with PAO1 (Fig.
3G; see Fig. S5C in the supplementalmaterial). Overall, these find-
ings indicate that TRPC1/mice exhibit impaired proinflamma-
tory responses following PAO1 infection compared to WT mice.
PKC is a critical link for TRPC1-mediated JNK/NF-B sig-
naling activation and inflammatory responses. Protein kinase
C (PKC) has been shown to be upstream in the regulation of
JNK and NF-B signaling (27, 28). We thus investigated whether
PKC is the crucial link for TRPC1-meidated JNK and NF-B
activation and inflammatory response. As shown in Fig. 4A and in
Fig. S8A in the supplemental material, deletion of TRPC1 mark-
edly reduced the phosphorylated PKC (Thr638) level induced by
bacterial infection. Similar to the case for TRPC1/ mice,
TRPC1-silenced MLE-12 cells also failed to elicit the activation of
PKC (Fig. 4B; see Fig. S8B in the supplemental material). Collec-
tively, these data indicate that PKC phosphorylation was in-
creased following bacterial infection in WT mouse lungs and
MLE-12 cells but decreased in both TRPC1/ mouse lungs and
TRPC1-silenced MLE-12 cells. Thus, TRPC1 may be a previously
undiscovered player between bacterial infection and PKC acti-
vation.
Using pharmacological inhibitors and genetic silencing strate-
gies, we showed that cells treated with PKC inhibitor or trans-
fected with PKC siRNA exhibited decreased phosphorylation of
JNKandNF-B (Fig. 4C; see Fig. S3B and S8C in the supplemental
material) upon bacterial infection. Moreover, PKC or TRPC1
silencing or PKC inhibitor treatment also reduced the expression
of IL-1, IL-6, and TNF- compared to that in controls (Fig. 4D).
Taken together, these data indicate that TRPC1 activated the JNK/
NF-B signaling pathway by directly regulating PKC, leading to
proinflammatory cytokine release.
To determine whether TRPC1/PKC signaling has a general
role in inflammatory responses to other bacterial infections, we
also used K. pneumoniae and another P. aeruginosa strain (PAK, a
more cytotoxic strain than PAO1) to infect MH-S cells to test the
corresponding immunity. Similar to the results of PAO1 infec-
tion, the expression levels of IL-1, IL-6, andTNF-were lower in
MH-S cells transfected with TRPC1 siRNA or PKC siRNA than
in cells transfected with siRNAnegative controls (see Fig. S9 in the
supplemental material), suggesting that TRPC1/PKC signaling
has a ubiquitous activity in regulating inflammatory responses in
both alveolar macrophages and epithelial cells.
FIG4 PKC as the TRPC1 effectormediates JNK/NF-B activation and inflammatory responses. (A)Micewere intranasally infectedwith 1 107 CFUof PAO1
for 24 h (n 5). Lung tissues were lysed to assess the levels of p-PKC and PKC byWestern blotting. GAPDH served as the loading control. (B) MLE-12 cells
were transfected with various siRNAs (50 nM). After 24 h, the cells were infected with PAO1 at anMOI of 10:1 for 1 h. Cells were treated with 25MSKF-96365
for 30 min before PAO1 infection. Cells were lysed and were used to assess the levels of p-PKC and PKC. (C) MLE-12 cells were transfected with scrambled
or PKC siRNA (50 nM) for 24 h. The cells were then infected with PAO1 at anMOI of 10:1 for 1 h. The cells were treated with 3MPKC inhibitor (Go6976)
30 min before PAO1 infection. Equal numbers of the cells were lysed and were used to assess the levels of p-JNK and p-NF-B p65 (Ser536). GAPDH served as
the loading control. (D)MH-S cells were transfectedwith various siRNAs (50 nM) for 24 h and then infectedwith PAO1 at anMOI of 10:1 for 1 h, and polymyxin
B (100 g/ml) was added into the medium and left for another 15 h. Cells were treated with 3 M PKC inhibitor (Go6976) 30 min before bacterial infection.
Different cytokines in the supernatant were measured by a standard ELISA.
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TLR4 is essential for TRPC1 function upon P. aeruginosa
infection. Since the production of DAG and IP3-mediated Ca
2
entry from the plasma membrane can be induced by TLR4 after
the treatment of lipoproteins, lipoteichoic acid, or LPS, which
facilitates the translocation of PKC from the cytosol to the
plasma membrane (29, 30), we reasoned that TLRs may activate
the TRPC1 channel to regulate PKC signaling. Importantly, fol-
lowing PAO1 infection, TRPC1/ mice showed decreased TLR
expression compared to WT mice (Fig. 5A; see Fig. S10A in the
supplemental material). Additionally, expression levels of TRPC1
and TLR2/4 proteins were increased in a time-dependent manner
upon bacterial infection, with TLR4 increasing earlier and more
strongly than TLR2 (Fig. 5B; see Fig. S10B in the supplemental
material). Moreover, silencing of TLRs by use of siRNAs, as vali-
dated in our previous report (31), had no effects on ER Ca2
levels, but the bacterium-dependent increase in Ca2 entry (as
observed in Fig. 2) was significantly inhibited (Fig. 5C; see Fig.
S11A in the supplemental material). Coupled with LPS-mediated
TRPC1 channel excitation, these data indicate that time-depen-
dent TLR4 signaling may contribute to TRPC1-mediated Ca2
entry and to its associated downstream events, including cytokine
secretion.
To further establish the link between TLR4 and TRPC1, we
investigated whether store depletion is needed for TRPC1 activa-
tion. Since PLC- has been implicated in LPS-induced TLR4-me-
diated Ca2 release from the ER stores, which is necessary for
regulating cellular functions of TRPC1 (32–34), we then investi-
gated the effect of PLC- on Ca2mobilization in our model. As
expected, inhibition of PLC- by U73122 significantly decreased
LPS-induced Ca2 entry and TRPC1 expression in a time-depen-
dent manner (Fig. 5D). Similarly, inhibition of TLR4 using the
chemical antagonist E5564 (kindly provided by Eisai Co.) also
showed a decrease in TRPC1-mediated Ca2 currents (see Fig.
S11B in the supplemental material). Importantly, these Ca2 cur-
rents were initiated by store depletion, as IP3 in the patch pipette
showed similar Ca2 currents, which were not further potentiated
by the addition of LPS and were also not inhibited by TLR4 inhi-
bition (see Fig. S11C in the supplemental material), suggesting
that in bacterial infection, TRPC1 activation is involved in PLC-
signaling in the TLR4-dependent store depletion mechanism.
We next assessed the role of TLR2/4 in PKC signaling and
showed that PKC phosphorylation was decreased when cells
were transfected with either TLR2 siRNA or TLR4 siRNA (Fig. 5E;
see Fig. S10C in the supplemental material), while TLR4 played a
dominant role. These findings suggest that TLR4 is essential to
link TRPC1 to PKC in bacterial infection.
Thus, the overall data demonstrate that the TRPC1-PKC-
JNK-NF-B circuit is critically involved in Gram-negative bacte-
rial infection, which modulates the proinflammatory response
against the invading bacteria. A breakdown in this defense mech-
anism results in a significantly weakened host defense, leading to a
severe infection phenotype as observed in TRPC1/ mice and
cultured cells. To illustrate the molecular mechanism involved in
bacterial infection, we illustrated a model for the cellular signal-
ing, which shows that Gram-negative bacterial infection induces
TLR4 activation leading to store depletion followed by the activa-
FIG 5 TLR4 is essential for TRPC1 function upon P. aeruginosa infection. (A) WT and TRPC1/mice were intranasally infected with 1 107 CFU of PAO1
for 24 h (n 5). Lung tissues were lysed to assess the levels of various proteins using different antibodies as indicated. GAPDH served as the loading control. (B)
Time-dependent expression of TRPC1 and TLR2/4 in the lung tissues of WT mice. The mice were infected with PAO1 for up to 48 h. (C) Ca2 imaging was
performed in the presence of LPS under various conditions inMLE-12 cells. Analog plots and quantification of the fluorescence ratio (340/380) from an average
of 50 to 80 cells are shown. (D) Ca2 imaging was performed in the presence of LPS under treatment with PLC- inhibitor (U73122) inMH-S cells infected with
PAO1. Analog plots of the fluorescence ratio (340/380) from an average of 50 to 80 cells are shown. Quantification of the fluorescence ratio (340/380) from an
average of 100 to 125 cells infected with PAO1 under various conditions is shown. (E) MLE-12 cells were transfected with various siRNAs (50 nM). After 24 h,
the cells were infected with PAO1 at an MOI of 10:1 for 1 h. Cells were lysed and were used to assess the levels of p-PKC and PKC. One-way ANOVA with a
post hoc test was used. *, P 0.05. The data are representative of three experiments.
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tion of TRPC1, which subsequently mediates inflammatory re-
sponse through the TRPC1/PKC/JNK/NF-B pathway (Fig. 6).
DISCUSSION
Previous studies have demonstrated that TRPC1 is associatedwith
lipid rafts, a critical cell signaling initiator formed during bacterial
infections; we thus surmise that TRPC1may play a key role in the
host response against bacterial infection in lung epithelial cells
(35). Although studies have illustrated the role of TRPC1 in the
cell cycle, cell proliferation, and many other processes (6, 11, 36),
its role in innate immunity against whole microorganisms is not
yet identified. In this study, we showed thatP. aeruginosa infection
facilitated the activation of Ca2 influx via the TRPC1 channel.
Furthermore, the endogenous Ca2 entry channel that was acti-
vated by TLR was similarly observed as TRPC1-dependent ISoc
currents (16), which were increased in P. aeruginosa- andK. pneu-
moniae-infected cells. Our findings suggest that TRPC1 may aug-
ment immunity against Gram-negative bacterial infection.
Combating bacterial infection requires robust inflammatory
responses, but excessive inflammation can dampen immunity and
thus worsen disease. Our current study indicates that TRPC1/
mice succumb to infection due to decreased inflammatory re-
sponses and subsequent ineffective bacterial clearance. It has been
suggested that TPRC1 is necessary for lymphocyte biological func-
tion and is a regulator of lung hyperresponsiveness during the
allergen-induced pulmonary response (37). Previous findings also
indicate that lung epithelial cells may play a key role in the pro-
duction of proinflammatory cytokines (25, 26). Consistent with
previous studies, we also found that activation of two signaling
proteins (JNK and NF-B) was blunted in both TPRC1-silenced
epithelial cells and TRPC1/mice (38, 39). Critically, we reveal a
new mechanism by identifying that Ca2 entry via TRPC1 is es-
sential for the activation. As expected, JNK inhibition decreased
NF-B activation and reduced inflammatory responses, indicat-
ing that JNK activation is required for NF-B activation and ini-
tiation of the downstream inflammatory response. Interestingly,
others reported that p38 was involved in the NF-B pathway, and
this variationmay be related to themodel system used; perhaps in
vivo signaling is involved a complex and coordinated regulatory
mechanism (40, 41). Taken together, our data suggest that TRPC1
initiates a positive regulation in the JNK/NF-B pathway, which
seems important for control of human pathogens. Therefore,
TRPC1 deficiency leads to a lowered cytokine response and
thereby a worsened host defense phenotype.
To further probe how TRPC1 can regulate the activation of
JNK and NF-B, we focused on the role of PKC, a serine- and
threonine-specific protein kinase that can regulate the activation
of JNK and NF-B (27, 28). Activation of PKC is induced by
Ca2 and the second messenger DAG (42, 43); however, the ion
channel that initiates Ca2 entry, thereby regulating PKC activity,
is not yet identified. Here, we show that TRPC1 regulates the ac-
tivation of PKC, which was dependent on TRPC1-mediated
Ca2 entry.
In addition, TLR4 is also a critical signal that induces the pro-
duction of second messengers while serving as a pathogen recog-
nition receptor (29, 30, 44) to activate the TRPC1 channel. Impor-
tantly, we identified that TRPC1-mediated activation of PKC
can induce the activation of JNK and NF-B. These observations
offered a model describing that bacterial infection induces TLR4-
mediated activation of TRPC1, which initiates Ca2 entry to acti-
vate PKC, which functions as an effector in inducing JNK and
NF-B, which are critical for cytokine production and bacterial
clearance. We noticed that TLR4 responds to P. aeruginosa infec-
tion earlier andmore strongly thanTLR2, that the TRPC1 channel
is also excited by LPS, and that the signaling is impaired by both
TLR4 siRNA silencing and the E5564 inhibitor. These data indi-
cate that TLR4 is upstream of the TRPC1 pathway, though TLR2’s
involvement cannot be completely excluded at this time. In addi-
tion, the function of PLC- in Ca2 mobilization in our system
was consistent with that described in previous reports (32–34).
These data indicate that the PLC- pathway plays an important
role in bacterial ligand-induced TRPC1 activation. However, the
detailed mechanism of PLC- in the activation of TRPC1 and
whether other signals also contribute to this process need further
investigation. Moreover, PKC has been shown to phosphorylate
TRPC1 and serves as an important determinant of Ca2 entry,
indicating that there might also be positive feedback in TRPC1/
PKC-mediated immune signaling (45). In a more recent study,
TRPC1 KO mice exhibited decreased IL-1 levels in Escherichia
coli LPS-mediated sepsis models, and this variation again may be
due to different LPS species involved (15). Nevertheless, the data
from the current study are largely based on a bacterial model,
which has not been evaluated before. Our study also evaluated
other calcium channels and their regulators (i.e., STIM1) for pro-
tein expression and function, as well as ER-mediated calcium en-
try. Although TRPC1 may function as an immunity regulator in
bacterial infection via STIM1 signals, there was no significant al-
teration in protein expression for STIM1/Orai1, IPR3, and
SERCA1 (Fig. 2K), suggesting that TRPC1 appears to be a domi-
nant player during bacterial infection, particularly in its associated
inflammatory responses. Although TRPC1 is identified as a new
immunity regulator, host immunity may be related to an increas-
ingly complex network, and other Ca2 entry channels (i.e.,
STIM1/Orai1) might also play a role in this process.
Overall, our data demonstrate a typical phenotype of bacterial
infection in TRPC1/ mice and suggest an important role for
TRPC1 in the innate immunity against human pathogens. TRPC1
deficiency impaired the phagocytic ability and other immune de-
FIG 6 Schematic describing the proposed TRPC1/PKC/JNK/NF-B axis
involved in the dysregulated proinflammatory response during bacterial
infection.
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fensemechanisms, resulting in decreased infiltration of leukocytes
into the lung and a greatly attenuated inflammatory response. In
particular, the impaired immune function in TRPC1/ mice is
highly attributable to dysregulatory effects on the TRPC1/PKC/
JNK/NF-B axis, which governs the inflammatory process. Fur-
thermore, at the upstream point of this immune circuit, TLR4-
mediated activation of TRPC1 followed by PKC is required to
initiate and control the host defense response. Collectively, these
findings provide novel insight into the role of TRPC1 in the innate
immune reaction against bacteria, indicating novel targets to
combat bacterial invasion.
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SUPPLEMENTARY FIGURES LEGENDS 8 
Figure S1. Increased bacterial invasion and decreased PMN infiltration in TRPC1-/- mice. 9 
(A and B) In vivo imaging of bacterial infected mice (n=5). TRPC1-/- mice and WT mice were 10 
intranasally challenged with 1107 CFU/mouse of Xen-41 (a bioluminescent strain of P. 11 
aeruginosa). Then the mice were monitored up to 24 h. (A) Images showing bioluminescence 12 
in the lung at different time points were obtained using IVIS XRII system. (B) The lungs of 13 
WT and TRPC1-/- mice were taken images with IVIS XRII system at 24 h. (C) Mice were 14 
infected with 1107 CFU of PAO1 and sacrificed at 24 h post-infection (n=5). Lung and serum 15 
were aseptically collected to evaluate PMN infiltration. PMN cell percentages in the lung and 16 
serum were calculated versus total nuclear cells via HEMA-3 staining. Data are shown as 17 
means ± SDEVs and representative of three experiments (*p<0.05 by Student’s t test). 18 
 19 
Figure S2. Validation of the function of AMs. (A) TRPC1-/- and WT mice were irradiated 20 
(800rds) and administered antibiotics via treated drinking water (using 250 units/ml penicillin 21 
and 250 g/ml Streptomycin). 10 million bone marrow cells from donor mice were injected 22 
into each recipient mouse via i.v. immediately after the isolation. 45 days later, these mice 23 
were challenged with Pa infection (n= 6 in each set of animals). BAL fluid was collected at 24 24 
2 
  
h and AMs in the precipitate were lysed. The colony formation units in the same number of 1 
AMs were calculated. (B) Same amounts of AM cells isolated from the TRPC1-/- and WT mice 2 
(n=5) were infected with PAO1-GFP at MOI 10:1 for 1 h. Fluorescence intensity showed 3 
decreased phagocytosis in TRPC1-/- mice. (C, D) Ca2+ imaging was performed in the presence 4 
of thapsigargin (2 M) in various conditions in primary alveolar macrophages (AM) cells from 5 
(A). Analog plots of the fluorescence ratio (340/380) from an average of 40-60 cells are shown 6 
and been quantified. Data in was plotted as means ± SDEVs calculated by One-Way ANOVA 7 
with Tukey's post-hoc; (*p<0.05). All in vitro experiments were performed at least three times 8 
with similar results. 9 
 10 
Figure S3. Verification of the function of siRNAs and Ca2+ currents. (A-B) MLE-12 cells 11 
were transfected with scrambled, TRPC1, or PKC siRNA at 50 nM. Protein lysates prepared 12 
24 h post-transfection were analyzed for (A) TRPC1 and (B) PKC expression by western 13 
blotting. GAPDH serves as the loading control. (C) Ca2+ imaging was performed in the 14 
presence of Tg (1µM) on MLE-12 cell. Analog plots of the fluorescence ratio (340/380) from 15 
an average of 40-60 cells are shown and been quantified (shown as bar graph in D). (E) Basal 16 
control of Ca2+ imaging was performed in the presence of Pa on MLE-12 cell. 17 
 18 
Figure S4. Bacterial infection facilitated Ca2+ influx. (A) Ca2+ imaging was performed in the 19 
presence of LPS (100 ng/ml) in scrambled siRNA and TRPC1 siRNA transfected MLE-12 20 
cells. Analog plots and quantification of the fluorescence ratio (340/380) from an average of 21 
40-60 cells are shown. (B and C) LPS-induced currents were evaluated in scrambled and 22 
TRPC1 siRNA transfected MLE-12 cells with the holding potential at -80mV (B). 23 
3 
  
Representative IV curves under these conditions and the average (8-10 recordings) current 1 
intensity under various conditions are shown in (D). (E) MLE-12 cells were transfected with 2 
scrambled siRNA, STIM1 siRNA for 48 h and Ca2+ imaging was performed in the presence of 3 
LPS (100 ng/ml) in control, siSTIM1 MLE-12 cells. Analog plots of the fluorescence ratio 4 
(340/380) from an average of 40-60 cells’ peak values are shown and been quantified in (F). 5 
Western blots showing decreased expression of STIM1 using siRNAs are shown in inset.  Ca2+ 6 
imaging was performed in the presence of OAG (100 M) in control and Pa-treated (15min 7 
and 30min) MLE-12 cells. Analog plots of the fluorescence ratio (340/380) from an average of 8 
40-60 cells are shown after quantification. Data in (A, C, D) were plotted as means ± SDEVs 9 
calculated by Student’s t test (A, C) or One-Way ANOVA with Tukey's post-hoc (D); 10 
(*p<0.05). All experiments were performed at least three times with similar results. 11 
 12 
Figure S5. Densitometric quantification of the western blotting gel data presented in Fig. 3 13 
using Quantity One software. (A) Densitometric quantification of the western blotting gel 14 
data presented in Fig. 3A. (B) Densitometric quantification of the western blotting gel data 15 
presented in Fig. 3C. (C) Densitometric quantification of the western blotting gel data 16 
presented in Fig. 3G.  17 
 18 
Figure S6. The expression trend of TLRs-relevant genes. WT mice were intranasally 19 
infected with 1×107 CFU/mouse of PAO1 for different time points. Lung tissues were lysed to 20 
assess the levels of various signaling proteins. p-JNK, JNK, p-NF-B p65 (Ser536), NF-B 21 
p65, TNF-α and IL-6 levels were determined by western blotting. GAPDH serves as the 22 
loading control. Densitometric quantification of the western blotting gel data was used by 23 
4 
  
Quantity One software. The data are representative of three experiments. 1 
 2 
Figure S7. Elevated activation of NF-B induced upon bacterial infection in MLE-12 cells. 3 
(A) The translocation of p-JNK and p-NF-B p65 after PAO1 infection using immune 4 
staining. Cells were pre-treated with 20 µM JNK inhibitor SP600125 and 50 µg/ml NF-κB 5 
inhibitor SN50 for 30 min before infection. DAPI was used to stain the nucleus. (B) Activation 6 
of NF-κB was detected using a luciferase promoter assay. Transient transfections were 7 
performed 24 h before infection. PAO1 infection at 10:1 MOI for 1 h and cell lysates were 8 
subjected to luciferase activity analysis using the Dual-Luciferase Reporter Assay System. The 9 
data are representative of three experiments (*p<0.05). Average values and SDEVs were 10 
calculated by One-Way ANOVA with Tukey's post-hoc. The data are representative of three 11 
experiments. 12 
 13 
Figure S8. Densitometric quantification of the western blotting gel data presented in Fig. 4 14 
using Quantity One software. (A) Densitometric quantification of the western blotting gel 15 
data presented in Fig. 4A. (B) Densitometric quantification of the western blotting gel data 16 
presented in Fig. 4B. (C) Densitometric quantification of the western blotting gel data 17 
presented in Fig. 4C.  18 
 19 
Figure S9. TRPC1 has similar function in host defense against K. pneumoniae and PAK 20 
infection. MH-S cells were transfected with scrambled or TRPC1, or PKC siRNA (50 nM) 21 
for 24 h. Then the cells were infected with Kp or PAK (another Pa strain with more cellular 22 
toxicity to validate the PAO1 data as a comparison) at MOI 10:1 for 1 h and polymyxin B (100 23 
5 
  
g/ml) was added into the medium for another indicated time. Different cytokines in the 1 
supernatant of MH-S cells were measured by a standard ELISA 16 h after bacterial infection. 2 
Data are plotted as means ± SDEVs calculated by One-Way ANOVA with Tukey's post-hoc. 3 
(*p<0.05). All experiments were performed at least three times with similar results. 4 
 5 
Figure S10. Densitometric quantification of the western blotting gel data presented in Fig. 5 6 
using Quantity One software. (A) Densitometric quantification of the western blotting gel 7 
data presented in Fig. 5A. (B) Densitometric quantification of the western blotting gel data 8 
presented in Fig. 5B. (C) Densitometric quantification of the western blotting gel data 9 
presented in Fig. 5E.  10 
 11 
Figure S11. TLR4 mediated signaling facilitated Ca2+ influx. (A) Ca2+ imaging was 12 
performed in the presence of LPS in scrambled and MyD88 siRNA transfected MH-S cells. 13 
Quantification of fluorescence ratio (340/380) from an average of 100-125 under various 14 
conditions infected with PAO1 is shown. (B) Representative IV curves under the treatment of 15 
the TLR4inhibitor, E5564, infected with PAO1 in MH-S cells and the average (8-10 16 
recordings) current intensity (at -80mV) in control and Pa-treated are shown. (C) 17 
Representative IV curves and the average (8-10 recordings) current intensity (at -80mV) in 18 
E55564 treated MH-S cells in the persistence of additional IP3. Data in (A-D) were plotted as 19 
means ± SDEVs calculated by One-Way ANOVA with Tukey's post-hoc (A, and D) or 20 
Student’s t test (B-C); (*p<0.05). All experiments were performed at least three times with 21 
similar results.  22 
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